دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life
Dipak Kotecha, MD, PhD, MSc1,2,3; Karina V. Bunting, PhD, MSc1,2; Simrat K. Gill, MD, MPharm1,2; Samir Mehta, MSc4; Mary Stanbury5; Jacqueline C. Jones5; Sandra Haynes, MBE, MBA5; Melanie J. Calvert, PhD3,6,7; Jonathan J. Deeks, PhD, MSc, CStat4,6; Richard P. Steeds, MD, MA1,2; Victoria Y. Strauss, PhD, MSc8; Kazem Rahimi, DM, MSc9; A. John Camm, MD10; Michael Griffith, MD1,2; Gregory Y. H. Lip, MD11,12; Jonathan N. Townend, MD1,2; Paulus Kirchhof, MD1,13,14; for the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) Team
doi : 10.1001/jama.2020.23138
JAMA. 2020;324(24):2497-2508
There is little evidence to support selection of heart rate control therapy in patients with permanent atrial fibrillation, in particular those with coexisting heart failure.
Effect of a Lower vs Higher Positive End-Expiratory Pressure Strategy on Ventilator-Free Days in ICU Patients Without ARDS
Writing Committee and Steering Committee for the RELAx Collaborative Group
doi : 10.1001/jama.2020.23517
JAMA. 2020;324(24):2509-2520
It is uncertain whether invasive ventilation can use lower positive end-expiratory pressure (PEEP) in critically ill patients without acute respiratory distress syndrome (ARDS).
Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States
Hyuna Sung, PhD1; Noorie Hyun, PhD2; Corinne R. Leach, PhD, MPH, MS3; K. Robin Yabroff, PhD1; Ahmedin Jemal, DVM, PhD1
doi : 10.1001/jama.2020.23130
JAMA. 2020;324(24):2521-2535
The number of cancer survivors who develop new cancers is projected to increase, but comprehensive data on the risk of subsequent primary cancers (SPCs) among survivors of adult-onset cancers are limited.
Uptake and Accuracy of the Diagnosis Code for COVID-19 Among US Hospitalizations
Sameer S. Kadri, MD1; Jake Gundrum, MS2; Sarah Warner, MPH1; Zhun Cao, PhD2; Ahmed Babiker, MBBS3; Michael Klompas, MD4; Ning Rosenthal, MD, PhD, MPH2
doi : 10.1001/jama.2020.20323
JAMA. 2020;324(24):2553-2554
Psychological Distress and COVID-19–Related Stressors Reported in a Longitudinal Cohort of US Adults in April and July 2020
Emma E. McGinty, PhD1; Rachel Presskreischer, MS1; Kelly E. Anderson, MPP1; Hahrie Han, PhD2; Colleen L. Barry, PhD1
doi : 10.1001/jama.2020.21231
JAMA. 2020;324(24):2555-2557
Accelerating Global Improvements in Health Care Quality
Sheila Leatherman, MSW1; Donald M. Berwick, MD, MPP2
doi : 10.1001/jama.2020.17628
JAMA. 2020;324(24):2479-2480
A Roadmap to Advance Patient Safety in Ambulatory Care
Hardeep Singh, MD, MPH1; Pascale Carayon, PhD2
doi : 10.1001/jama.2020.18551
JAMA. 2020;324(24):2481-2482
Assessing Progress in Health Care Quality Through the Lens of COVID-19
Janet M. Corrigan, PhD1; Carolyn M. Clancy, MD2,3
doi : 10.1001/jama.2020.17392
JAMA. 2020;324(24):2483-2484
Progress in Patient Safety in Anesthesia
Emily Methangkool, MD, MPH1; Daniel J. Cole, MD1; Maxime Cannesson, MD, PhD1
doi : 10.1001/jama.2020.23205
JAMA. 2020;324(24):2485-2486
The Light Princess
Annette M. Chavez, MD1
doi : 10.1001/jama.2020.24033
JAMA. 2020;324(24):2487-2488
Two Decades Since To Err Is Human
Victor J. Dzau, MD1; Kenneth I. Shine, MD2
doi : 10.1001/jama.2020.23151
JAMA. 2020;324(24):2489-2490
Searching for the Optimal PEEP in Patients Without ARDS
Sarina K. Sahetya, MD, MHS1; Ewan C. Goligher, MD, PhD2,3,4; Arthur S. Slutsky, MD2,5
doi : 10.1001/jama.2020.23067
JAMA. 2020;324(24):2490-2492
Incorporating the Risk for Subsequent Primary Cancers Into the Care of Adult Cancer Survivors
Patricia A. Ganz, MD1,2,3; Jacqueline N. Casillas, MD, MSHS3,4
doi : 10.1001/jama.2020.23410
JAMA. 2020;324(24):2493-2495
JAMA Health Forum—A New JAMA Network Specialty Journal
Howard Bauchner, MD1; John Z. Ayanian, MD, MPP2,3; Melinda B. Buntin, PhD4,5; Annette Flanagin, RN, MA6; Brian Shields, MBA7
doi : 10.1001/jama.2020.23376
JAMA. 2020;324(24):2495-2496
Gastroesophageal Reflux Disease
John Maret-Ouda, MD, PhD1,2; Sheraz R. Markar, MD, PhD1,3; Jesper Lagergren, MD, PhD1,4
doi : 10.1001/jama.2020.21360
JAMA. 2020;324(24):2536-2547
Gastroesophageal reflux disease (GERD) is defined by recurrent and troublesome heartburn and regurgitation or GERD-specific complications and affects approximately 20% of the adult population in high-income countries.
Caring for Emergency Department Patients With Complex Medical, Behavioral Health, and Social Needs
Jack Chase, MD1; Jenna Bilinski, RN, MBA2; Hemal K. Kanzaria, MD, MSc3
doi : 10.1001/jama.2020.17017
JAMA. 2020;324(24):2550-2551
Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19
Gregory Piazza, MD, MS1; David A. Morrow, MD, MPH2
doi : 10.1001/jama.2020.23422
JAMA. 2020;324(24):2548-2549
Digitalis Glycosides for Heart Rate Control in Atrial Fibrillation
Gregory Curfman, MD1
doi : 10.1001/jama.2020.24578
JAMA. 2020;324(24):2508
Musical Spine Surgeons Lift Spirits With Songs of Hope
Rita Rubin, MA
doi : 10.1001/jama.2020.21152
JAMA. 2020;324(24):2472-2474
Hospital Readmission Is Common Among COVID-19 Survivors
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.23910
JAMA. 2020;324(24):2477
Shifts in Emergency Mental Health Care for Youth During the Pandemic
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2020.24480
JAMA. 2020;324(24):2477
Exercise Intensity Unrelated to Older Adults’ Mortality Risk
Anita Slomski
doi : 10.1001/jama.2020.23342
JAMA. 2020;324(24):2476
Empagliflozin Cuts Cardiovascular Deaths in Advanced Heart Failure
Anita Slomski
doi : 10.1001/jama.2020.24667
JAMA. 2020;324(24):2476
High-Calorie Treatment Leads to Faster Gains in Anorexia Nervosa
Anita Slomski
doi : 10.1001/jama.2020.24669
JAMA. 2020;324(24):2476
Reliving Childhood Trauma Details Isn’t Needed to Treat PTSD
Anita Slomski
doi : 10.1001/jama.2020.24671
JAMA. 2020;324(24):2476
Early Physical Therapy Relieves Sciatica Disability and Pain
Anita Slomski
doi : 10.1001/jama.2020.24673
JAMA. 2020;324(24):2476
More Transparency Needed for COVID-19 Emergency Authorizations
Rita Rubin, MA
doi : 10.1001/jama.2020.24201
JAMA. 2020;324(24):2475
Postpartum Depression Persists Longer Than Previously Thought
Rita Rubin, MA
doi : 10.1001/jama.2020.24649
JAMA. 2020;324(24):2475
Pharmacies Partner With HHS to Provide COVID-19 Vaccines
Rita Rubin, MA
doi : 10.1001/jama.2020.24651
JAMA. 2020;324(24):2475
Graphic Medicine—The Best of 2020
Michael J. Green, MD, MS1; Shelley Wall, AOCAD, MScBMC, PhD, CMI2,3
doi : 10.1001/jama.2020.19479
JAMA. 2020;324(24):2469-2471
An Essential Worker’s List of Pandemic Chores for the Kids
Wendy Stead, MD1
doi : 10.1001/jama.2020.18681
JAMA. 2020;324(24):2560
Gastroesophageal Reflux Disease
John Maret-Ouda, MD, PhD1; Sheraz R. Markar, MD, PhD1; Jesper Lagergren, MD, PhD1
doi : 10.1001/jama.2020.21573
JAMA. 2020;324(24):2565
Peyronie Disease
Christopher D. Gaffney, MD1; James A. Kashanian, MD1
doi : 10.1001/jama.2020.14819
JAMA. 2020;324(24):2566
Cross-Training in Neurology and Psychiatry
Liam C. Butchart, BA1
doi : 10.1001/jama.2020.21927
JAMA. 2020;324(24):2557-2558
Cross-Training in Neurology and Psychiatry—Reply
Matcheri S. Keshavan, MD1; Bruce H. Price, MD2; Joseph B. Martin, MD, PhD3
doi : 10.1001/jama.2020.21930
JAMA. 2020;324(24):2558
